Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
39
NMPA:39
Drug Approvals
Galantamine Hydrobromide Orally Disintegrating Tablets
- Product Name
- 氢溴酸加兰他敏口腔崩解片
- Approval Number
- 国药准字H20244023
- Approval Date
- Jun 18, 2024
NMPA
Galantamine Hydrobromide Orally Disintegrating Tablets
- Product Name
- 氢溴酸加兰他敏口腔崩解片
- Approval Number
- 国药准字H20244021
- Approval Date
- Jun 18, 2024
NMPA
Galantamine Hydrobromide Orally Disintegrating Tablets
- Product Name
- 氢溴酸加兰他敏口腔崩解片
- Approval Number
- 国药准字H20244022
- Approval Date
- Jun 18, 2024
NMPA
Oseltamivir Phosphate for Suspension
- Product Name
- 磷酸奥司他韦干混悬剂
- Approval Number
- 国药准字H20223198
- Approval Date
- Apr 8, 2022
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20223173
- Approval Date
- Mar 29, 2022
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20223174
- Approval Date
- Mar 29, 2022
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20223172
- Approval Date
- Mar 29, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found